STERIS plc (STE)
Market Cap | 20.48B |
Revenue (ttm) | 5.33B |
Net Income (ttm) | 434.80M |
Shares Out | 98.71M |
EPS (ttm) | 4.37 |
PE Ratio | 34.87 |
Forward PE | 21.60 |
Dividend | $2.28 (1.10%) |
Ex-Dividend Date | Nov 19, 2024 |
Volume | 419,927 |
Open | 203.70 |
Previous Close | 204.34 |
Day's Range | 203.70 - 208.42 |
52-Week Range | 197.82 - 248.24 |
Beta | 0.83 |
Analysts | Buy |
Price Target | 262.50 (+26.51%) |
Earnings Date | Feb 5, 2025 |
About STE
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions... [Read more]
Financial Performance
In 2023, STERIS's revenue was $5.14 billion, an increase of 13.28% compared to the previous year's $4.54 billion. Earnings were $378.24 million, an increase of 253.40%.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for STE stock is "Buy." The 12-month stock price forecast is $262.5, which is an increase of 26.51% from the latest price.
News
Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'
I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted EP...
STERIS plc (STE) Q2 2025 Earnings Call Transcript
STERIS plc (STE) Q2 2025 Earnings Call Transcript
Steris beats quarterly estimates on continued demand for medical procedures
Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools.
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) -- - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. ...
STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. ...
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter fin...
STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement
STERIS plc (STE, Financial), along with its subsidiaries STERIS Corporation, STERIS Limited, and STERIS Irish FinCo Unlimited Company, has entered into a significant financial arrangement with various...
15 Upcoming Dividend Increases Including A King
This week, 15 companies, including Dividend King Stanley Black & Decker, are set to increase dividends, with SWK extending its 57-year streak by 1.2%. My strategy focuses on buying, holding, and addin...
STERIS to Present at the Morgan Stanley Healthcare Conference
DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York C...
Steris: Q2 Numbers Solidify Buy Thesis
STE's Q1 FY'25 numbers were in line with expectations, with upsides in the healthcare and AST divisions. The company shows consistent free cash flow production and stable earnings on its capital base....
STERIS plc (STE) Q1 2025 Earnings Call Transcript
STERIS plc (NYSE:STE) Q1 2025 Earnings Conference Call August 7, 2024 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President & Chief Financial Officer D...
STERIS Announces Financial Results for Fiscal 2025 First Quarter
DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total re...
STERIS Raises Dividend to $0.57 per share
DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share....
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024
DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter fina...
PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
AUSTIN, Texas , June 3, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has completed the previously announce...
STERIS plc (STE) Q4 2024 Earnings Call Transcript
STERIS plc (NYSE:STE) Q4 2024 Earnings Conference Call May 9, 2024 9:00 AM ET Company Participants Julie Winter - VP, IR Mike Tokich - SVP and CFO Dan Carestio - President and CEO Conference Call Par...
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total ...
STERIS Announces Dividend of $0.52 per share
DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. ...
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter an...
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP
AUSTIN, Texas , April 11, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement t...
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) --) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental...
STERIS plc (STE) Q3 2024 Earnings Call Transcript
STERIS plc (STE) Q3 2024 Earnings Call Transcript
Steris beats third-quarter estimates on strong medical procedure demand
Medical equipment maker Steris beat third-quarter profit estimates, helped by strength in its core healthcare business driven by demand for surgical instruments as more patients catch up on procedures...
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Reven...
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter finan...